Mutya Harsch
2022
In 2022, Mutya Harsch earned a total compensation of $654.4K as Chief Legal Officer, General Counsel and Secretary at VYNE Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $143,538 |
---|---|
Option Awards | $30,750 |
Salary | $422,172 |
Stock Awards | $45,750 |
Other | $12,200 |
Total | $654,410 |
Harsch received $422.2K in salary, accounting for 65% of the total pay in 2022.
Harsch also received $143.5K in non-equity incentive plan, $30.8K in option awards, $45.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Mutya Harsch's compensation ranked 3,894th out of 5,736 executives tracked by ExecPay. In other words, Harsch earned more than 32.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,894 | 32nd |
Manufacturing | 2,205 | 29th |
Chemicals And Allied Products | 1,067 | 25th |
Drugs | 1,001 | 24th |
Pharmaceutical Preparations | 733 | 24th |
Harsch's colleagues
We found two more compensation records of executives who worked with Mutya Harsch at VYNE Therapeutics in 2022.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021